ArticleERJ open research2026
The development of a digital pathway for the assessment of residual excessive daytime sleepiness in obstructive sleep apnoea: a service evaluation.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the United Kingdom, national guidelines for obstructive sleep apnoea (OSA) highlight the importance of assessing continuous positive airways pressure (CPAP) compliance in order to identify patient cohorts of clinical importance, Methodology: The CDSS is a National Health Service framework-listed digital ecosystem comprising multiple clinical guided consultations encompassing the entire OSA pathway. Patients commenced on CPAP for ≥6 months and deemed "CPAP compliant" were identified from remote monitoring and subsequently underwent review using a clinical guided consultation (CGC). Patients identified with rEDS following CGC review were then discussed in an interhospital multidisciplinary team meeting, listed for a sleep study on CPAP and booked for consultant physician outpatient review. Results: 472 patients were identified as being CPAP compliant and underwent CGC review, with rEDS noted in 43 (9.7%) of them. rEDS was found to be significantly more common in those reporting chronic insomnia, symptoms of restless legs, dyspepsia, rhinitis and nocturia, as well as in current smokers, those prescribed key medications and in those not in current employment. The multidisciplinary team discussion and subsequent consultant review of the rEDS cohort was able to highlight specific factors requiring changes in patient management including those suitable for wake-promoting therapy. Conclusion: The incorporation of CDSS technology within a bespoke clinical pathway in order to review patients post CPAP initiation ensures that sleep services are able to readily identify and manage rEDS.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.